HLB Co., Ltd. (KOSDAQ:028300)
53,400
-1,300 (-2.38%)
May 30, 2025, 1:40 PM KST
HLB Co., Ltd. Revenue
HLB Co., Ltd. had revenue of 17.66B KRW in the quarter ending March 31, 2025, with 58.37% growth. This brings the company's revenue in the last twelve months to 74.64B, up 118.00% year-over-year. In the year 2024, HLB Co., Ltd. had annual revenue of 68.13B with 58.80% growth.
Revenue (ttm)
74.64B
Revenue Growth
+118.00%
P/S Ratio
96.13
Revenue / Employee
466.47M
Employees
160
Market Cap
7,174.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 68.13B | 25.23B | 58.80% |
Dec 31, 2023 | 42.90B | -136.81B | -76.13% |
Dec 31, 2022 | 179.71B | 109.88B | 157.37% |
Dec 31, 2021 | 69.83B | 13.65B | 24.30% |
Dec 31, 2020 | 56.18B | 17.76B | 46.22% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
Peptron | 3.15B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 125.90B |